Transcript localized inflammatory response
Inflammation
沈 弘 德 台北榮總教研部
本章大綱
• Leukocyte migration • Cell-adhesion molecules • Mediators of inflammation • The inflammatory process • Anti-inflammatory agents
Lymphocyte recirculation routes
* Extravasation * Cell-adhesion molecules (CAMs)
(endothelial cells & leukocytes)
- selectins - mucins - integrins - ICAMS * Receptors bind to CAMs
General structures of the four families of cell-adhesion molecules
* Glycosylated proteins * Heterodimeric proteins * Expressed by leukocytes * Facilitate adherence (LAD disease) * Interact with sialylated carbohydrate moieties of mucin-like molecules.
* Responsible for the initial stickiness of leukocytes to vascular endothelium. * Contain Ig/mucin-like domains * Expressed on endothelial cells * Bind to integrin/selectin molecules
Steps in neutrophil extravasation
Inflammatory response ↓ cytokines
,
inflammatory mediators Vascular endothelium activated Increased expression of CAMs The neutrophil tumbles end-over-end along the endothelium.
Neutrophil activation by chemoattractant stimulus: chemokines, PAF, C5a, C3a, C5b67, bacterial peptides Receptor activation induced conforma tional change in the integrin molecules → increased affinity & adhesion The neutrophil migrates through the vessel wall into the tissues.
Cell-adhesion molecules and chemokines involved in the first three steps of neutrophil extravasation rolling activation adhesion
Schematic cross-sectional diagram of a lymph node postcapillary venule with high endothelium (HEV)
As many as 1.4 x 10 4 lymphocytes extravasate every second through HEVs into a single lymph node.
Each of the secondary lymphoid organs, with the exception of the spleen, contains HEVs.
Lymphocytes attached to the surface of a high-endothelial venule
Naïve T cell tend to home to secondary lymphoid tissues through their HEV regions
Activation of a naïve cell occurs within secondary lymphoid tissue.
(Homing receptor) (Mucin-like CAM)
Steps in extravasation of a naïve T cell through a high endothelial venule into a lymph node
•
Activation of integrin molecules (a homing receptor)
•
Lymphocyte-specific chemoattractants
•
G-protein-coupled receptors
Mediators of inflammation
• Chemokines and other mediators released by tissue mast cells, blood platelets, leukocytes and lymphocytes. • Mediator-producing systems in plasma: - the kinin system - the clotting system - the fibrinolytic system - the complement system • Some lipids act as inflammatory mediators • Some cytokines are important inflammatory mediators
Chemokines
- key mediators of inflammation
Chemokines
• A superfamily of small polypeptides • Major regulators of leukocyte traffic (90-130 aa residues) (adhesion, chemotaxis, activation) • Involved in inflammation, homeostatic/developmental processes, angiogenesis, wound healing • Induced in response to infection → Assembly of leukocytes at sites of infection • > 50 chemokines , possess 4 conserved cysteine residues (C-C subgroup, C-X-C subgroup) • > 15 chemokine receptors (CC receptors, CXC receptors) • The interaction between chemokines and their receptors is of high affinity (
K a
> 10 9 ) and high specificity.
Chemokines signal through receptors coupled with heterotrimeric large G proteins
• • • •
Changes in shape of leukocytes Activation of integrins Generation of oxygen radicals Release of granular contents and proteases
Patterns of expression of some principal chemokine receptors on different classes of human leukocytes
*T H 1 cells: CCR1, -3, -5 T H 2 cells: CCR3, -4
*Chemokine-receptor profiles mediate leukocyte activity.
Plasma enzymes act as inflammatory mediators
Tissue damage induces formation of plasma enzyme mediators by the kinin system, the clotting system, and the fibrinolytic system
(a plasma clotting factor)
fibrinogen
C5 C5a +C5b mast cell degranulation & mediators release
The complement system
• anaphylatoxins (C3a, C4a, C5a) → mast cell degranulation & mediators (histamine…) release → increase vascular permeability induce smooth-muscle contraction • C3a, C5a and C5b67 → adhesion, extravasation and migration of monocytes and neutrophils • Influxes of fluid that carry antibody and phagocytic cells to the site of antigen entry.
Lipids act as inflammatory mediators
The breakdown of membrane phospholipids generates important mediators of inflammation, including thromboxane, prostaglandins, leukotrienes, PAF
(macrophages, monocytes, neutrophils and mast cells) (platelet activating factor)
Cytokines act as inflammatory mediators
• IL-1, IL-6, TNF a , IL-12, and many chemokines exhibit redundant and pleiotropic effects.
• IL-1, IL-6, TNF a : • IFN g : attracting & activating macrophages • IL-12: inducing the differentiation of the proinflammatory T H 1 subset
IFN-
g
: contributing to chronic inflammation by attracting and activating macrophages.
IL-12: induces the differentiation of the proinflammatory T H 1 subsets.
The inflammatory process
The inflammatory process
• acute inflammatory response (neutrophils, 10 10 /day) -
localized inflammatory response
(redness, swelling, heat, pain) - systemic acute-phase response • chronic inflammation (antigen persists) (macrophages) - IFN g - TNF a - fibrosis (scar formation) - granuloma formation • chronic inflammatory diseases
The major local manifestations of acute inflammation
Leukocyte emigration and accumulation in the site of injury.
extravasation of plasma fluid and proteins vascular dilation (erythema & warmth)
A localized acute inflammatory response
• redness & heat vasodilation - an increase in vascular diameter an increase in the volume of blood in the area & a reduction in the flow of blood • swelling an increase in vascular permeability leakage of fluid from the blood vessels an accumulation of fluid in the tissue (edema) extravasation of leukocytes • activation of the kinin, clotting, fibrinolytic and complement (C53a, C4a, C5a) systems
Macrophages:
- arrive about 5-6 hours after an inflammatory response begins - exhibit increased phagocytosis - exhibit increased release of mediators, cytokines and lytic enzymes that contribute to the inflammatory response (IL-1, IL-6, TNF a)
Overview of the cells and mediators involved in a local acute inflammatory response
(tissue damage)
*Tissue repair: TGF-
b
, proliferation of fibroblasts, deposition of extracellular matrix
The inflammatory process
• acute inflammatory response (neutrophils, 10 10 x 10 /day) - localized inflammatory response (redness, swelling, heat, pain) -
systemic acute-phase response
• chronic inflammation (antigen persists) (macrophages) - IFN g - TNF a - fibrosis (scar formation) - granuloma formation • chronic inflammatory diseases
Overview of the organs and mediators involved in a systemic acute-phase response
(inhibits the growth of pathogens)
The acute-phase response produces molecules that bind pathogens but not host cells.
On vertebrate cells , these mannose residues are covered by other sugar groups, especially by sialic acid while avoiding complement activation on host cell surfaces .
C/EBP is expressed constitutively in liver hepatocytes and promotes transcription of albumin and transthyretin genes
During an inflammatory response
Comparison of the structure and function of C/EBP and NF-IL6
*Both transcription factors are dimeric proteins containing a leucine-zipper domain and a basic DNA-binding domain.
*Both proteins bind to the same nucleotide sequence in the promoter or enhancer of the genes encoding various liver proteins.
Outcome of acute inflammation
The inflammatory process
• acute inflammatory response (neutrophils, 10 10 x 10 /day) - localized inflammatory response (redness, swelling, heat, pain) - systemic acute-phase response • chronic inflammation (antigen persists) (macrophages)
IFN-
g
TNF-
a - fibrosis (scar formation) - granuloma formation • chronic inflammatory diseases
A prolonged DTH response can lead to formation of a granuloma Lytic enzymes released from activated macrophages in a granuloma can cause extensive tissue damage.
Roles of IFN-
g
and TNF-
a
in chronic inflammation
Summary of pleiotropic activity of interferon gamma (IFN-
g
)
*Activated macrophages secrete TNF-a.
TNF-
a
acts synergistically with IFN-
g
to initiate a chronic inflammatory response.
Biological activities of TNF-
a (endotoxin)
*Endotoxin induces macrophages to produce TNF-
a
, which then acts to destroy the tumor .
Transgenic mouse (top) bearing a TNF-α transgene becomes anorectic and severely wasted
The inflammatory process
• acute inflammatory response (neutrophils, 10 10 x 10 /day) - localized inflammatory response (redness, swelling, heat, pain) - systemic acute-phase response • chronic inflammation (antigen persists) (macrophages) - IFN g - TNF a - fibrosis (scar formation) - granuloma formation •
chronic inflammatory diseases
*HEV-like regions: sites of lymphocyte extravasation into the inflamed tissue.
*IFN-
g
and TNF-
a
may play a role in the induction of HEV-like regions along the vasculature.
Leukocyte-adhesion deficiency (LAD) in humans and cattle
- A rare autosomal recessive disease - omphalitis (a swelling and reddening around the stalk of the umbilical cord) - Patients suffer recurrent and often chronic bacterial infections (
inability of their leukocytes to undergo adhesion-dependent migration into sites of inflammation
) - An absence of CD18 a number of integrins ) (an essential component of
Anti-inflammatory agents
Anti-inflammatory agents
•
Antibody therapies reduce leukocyte extravasation
- to block the activity of various adhesion molecules (anti-ICAM-1 + anti-LFA-1) •
Corticosteroids are powerful anti-inflammatory drugs
- reduction in the numbers and activity of immune-system cells - prevents NF k B activation - reduces the phagocytic and killing ability of macrophages and neutrophils - reduces chemotaxis - reduces expression of class II MHC molecules and IL-1 production by macrophages - reduces the release of lysosomal enzymes •
NSAIDs combat pain and inflammation
Corticosteroids
• • • lipophilic • can cross the plasma membrane • form receptor-hormone complex in the cytosol • transported to the nucleus • bind to specific regulatory DNA sequences induce increased transcription of the NF k B inhibitor (I • binding of I-kB to NF k B in the cytosol • prevent the translocation of NF k B into the nucleus k B) prevent NF k B activation of a number of genes (genes involved in T cell activation and cytokine production)
Inhibition of cyclooxygenase 1 and 2 by NSAIDs
*Cox-2-specific NSAIDs – inhibit inflammation and do not cause damage to the GI tract
Inflammation
• • • •
redness swelling heat pain
• •
immune-system cells mediators
Sequence of leukocyte events in inflammation (shown here for neutrophils)